|
显示项目 257176-257185 / 2348973 (共234898页)
<< < 25713 25714 25715 25716 25717 25718 25719 25720 25721 25722 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2023 |
Cisplatin or Doxorubicin reduces cell viability via the PTPIVA3- JAK2-STAT3 cascade in hepatocellular carcinoma
|
Li, Chao-Jen;Tsai, Hung-Wen;Chen, Yi-Li;Wang, Chun-I;Lin, Yang-Hsiang;Chu, Pei-Ming;Chi, Hsiang-Cheng;Huang, Yi-Ching;Chen, Cheng-Yi; Chen, Cheng-Yi; 陳政義 |
| 國立成功大學 |
2023 |
Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma
|
Li;Chao-Jen;Tsai;Hung-Wen;Chen;Yi-Li;Wang;Chun-;I;Lin;Yang-Hsiang;Chu;Pei-Ming;Chi;Hsiang-Cheng;Huang;Yi-Ching;Chen;Cheng-Yi |
| 國立成功大學 |
2013-01-01 |
Cisplatin Selects for Multidrug-Resistant CD133(+) Cells in Lung Adenocarcinoma by Activating Notch Signaling
|
Liu, Yu-Peng; Yang, Chih-Jen; Huang, Ming-Shyan; Yeh, Chi-Tai; Wu, Alexander T. H.; Lee, Yu-Cheng; Lai, Tsung-Ching; Lee, Chien-Hsin; Hsiao, Ya-Wen; Lu, Jean; Shen, Chia-Ning; Lu, Pei-Jung; Hsiao, Michael |
| 臺北醫學大學 |
2012 |
Cisplatin selects for multidrug-resistant CD133+
|
Liu, YP;Yang, CJ;Hung, MS;Yeh, CT;Wu, AT;Lee, YC;Lai, TC;Lee, CH;Hsiao, YW;Lu |
| 嘉南藥理大學 |
2020 |
Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression
|
Chen, Ming-Jenn; Chen, Po-Ming; Wang, Lee; Shen, Ching-Ju; Chen, Chi-Yi; Lee, Huei |
| 中山醫學大學 |
2020 |
Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression
|
Chen, MJ; Chen, PM; Wang, L; Shen, CJ; Chen, CY; Lee, H |
| 國立成功大學 |
2023 |
Cisplatin triggers oxidative stress, apoptosis and pro-inflammatory responses by inhibiting the SIRT1-mediated Nrf2 pathway in chondrocytes
|
Hsieh, P.-L.;Tsai, K.-L.;Chou, W.-C.;Wu, C.-H.;Jou, I.-M.;Tu, Y.-K.;Ma, C.-H. |
| 臺大學術典藏 |
2018-09-10T06:53:04Z |
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer
|
Cheng, A.-L. and Yeh, K.-H. and Lin, J.-T. and Hsu, C. and Liu, M.-Y.; KUN-HUEI YEH |
| 臺大學術典藏 |
2020-04-10T12:51:32Z |
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer
|
Liu M.-Y.;Chiun Hsu;Lin J.-T.;Yeh K.-H.;Cheng A.-L.; Cheng A.-L.; Yeh K.-H.; Lin J.-T.; Chiun Hsu; Liu M.-Y. |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer
|
ANN-LII CHENG; Yeh K.-H.; Lin J.-T.; Hsu C.; Liu M.-Y. |
显示项目 257176-257185 / 2348973 (共234898页)
<< < 25713 25714 25715 25716 25717 25718 25719 25720 25721 25722 > >>
每页显示[10|25|50]项目
|
